AbCellera Biologics Inc.
ABCL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001703057
In the last 90 days, AbCellera Biologics Inc. insiders filed 4 open-market purchases and 0 sales; 150 institutions reported holding it in 13F filings for Q2 2026, worth $908.8M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in AbCellera Biologics Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 128
- +1 vs. Q1 2025
- Shares held
- 107.6M
- −17.7M (−14.1%) vs. Q1 2025
- Total value
- $370.6M
- +$90.5M (+32.3%) vs. Q1 2025
- New holders
- 19
- 37 more added
- Sold out
- 18
- 44 more reduced
2 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ABCL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 150 | $908.8M |
| Q1 2026 | 138 | $434.0M |
| Q4 2025 | 144 | $370.6M |
| Q3 2025 | 141 | $524.6M |
| Q2 2025 | 128 | $370.6M |
| Q1 2025 | 129 | $280.1M |
| Q4 2024 | 146 | $333.9M |
| Q3 2024 | 139 | $274.6M |
| Q2 2024 | 148 | $338.3M |
| Q1 2024 | 154 | $547.4M |
| Q4 2023 | 143 | $681.1M |
| Q3 2023 | 138 | $551.8M |
| Q2 2023 | 170 | $809.1M |
| Q1 2023 | 183 | $980.7M |
| Q4 2022 | 203 | $1.30B |
| Q3 2022 | 190 | $1.21B |
| Q2 2022 | 162 | $1.26B |
| Q1 2022 | 130 | $1.10B |
| Q4 2021 | 124 | $1.63B |
| Q3 2021 | 116 | $1.98B |
| Q2 2021 | 114 | $1.99B |
| Q1 2021 | 86 | $2.42B |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding AbCellera Biologics Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Advisor Group Holdings, Inc. | 268,001 | $919.2K | 0.00% | +52,227+24.2% | Added |
| Skandinaviska Enskilda Banken AB (publ) | 340,267 | $1.17M | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 363,188 | $1.25M | 0.00% | +12,301+3.5% | Added |
| HRT Financial LP | 371,013 | $1.27M | 0.01% | +177,730+92.0% | Added |
| Royal Bank of Canada | 403,916 | $1.39M | 0.00% | +16,885+4.4% | Added |
| Driehaus Capital Management LLC | 499,922 | $1.71M | 0.01% | +499,922 | New |
| Lazard Asset Management LLC | 509,794 | $1.75M | 0.00% | −323,368−38.8% | Reduced |
| Intellectus Partners, LLC | 548,133 | $1.88M | 0.41% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 594,288 | $2.04M | 0.00% | +345,643+139.0% | Added |
| State Street Corp | 614,293 | $2.11M | 0.00% | −12,848−2.0% | Reduced |
| Norges Bank | 630,938 | $2.16M | 0.00% | 00.0% | Unchanged |
| Novo Holdings A/S | 652,529 | $2.24M | 0.16% | −474,386−42.1% | Reduced |
| Morgan Stanley | 996,927 | $3.42M | 0.00% | −294,089−22.8% | Reduced |
| Guardian Partners Inc. | 1,786,414 | $7.54M | 0.68% | 00.0% | Unchanged |
| Tang Capital Management LLC | 2,600,000 | $8.92M | 0.45% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,889,760 | $9.91M | 0.01% | +1,075,286+59.3% | Added |
| Renaissance Technologies LLC | 3,307,429 | $11.3M | 0.02% | +413,400+14.3% | Added |
| OrbiMed Advisors LLC | 3,344,568 | $11.5M | 0.29% | −836,200−20.0% | Reduced |
| Millennium Management LLC | 3,397,589 | $11.7M | 0.01% | +2,527,880+290.7% | Added |
| UBS Group AG | 3,447,925 | $11.8M | 0.00% | −1,634,258−32.2% | Reduced |
| BlackRock, Inc. | 3,680,794 | $12.6M | 0.00% | +104,586+2.9% | Added |
| Two Sigma Advisers, LP | 4,070,300 | $14.0M | 0.03% | +1,425,500+53.9% | Added |
| ArrowMark Colorado Holdings LLC | 4,105,095 | $14.1M | 0.25% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 4,110,852 | $14.1M | 0.03% | +984,063+31.5% | Added |
| UBS Asset Management Americas Inc | 8,471,619 | $29.1M | 0.01% | −7,199,444−45.9% | Reduced |
| Baillie Gifford & Co | 10,360,004 | $35.5M | 0.03% | −835,828−7.5% | Reduced |
| Capital World Investors | 13,361,096 | $45.8M | 0.01% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 27,525,640 | $94.4M | 0.92% | 00.0% | Unchanged |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −10,624,185−100.0% | Sold out |
| Prosight Management, LP | 0 | $0 | 0.00% | −2,815,652−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −64,304−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −54,918−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −46,621−100.0% | Sold out |
| Oxford Asset Management LLP | 0 | $0 | 0.00% | −28,241−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −25,622−100.0% | Sold out |
| Clarkston Capital Partners, LLC | 0 | $0 | 0.00% | −22,000−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −21,946−100.0% | Sold out |
| IMG Wealth Management, Inc. | 0 | $0 | 0.00% | −19,000−100.0% | Sold out |
| SIH Partners, LLLP | 0 | $0 | 0.00% | −17,163−100.0% | Sold out |
| AssuredPartners Investment Advisors, LLC | 0 | $0 | 0.00% | −15,356−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −14,584−100.0% | Sold out |
| Stratos Wealth Advisors, LLC | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| Evergreen Capital Management LLC | 0 | $0 | 0.00% | −11,633−100.0% | Sold out |
| Mariner, LLC | 0 | $0 | 0.00% | −10,966−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −135−100.0% | Sold out |
| Continuum Advisory, LLC | 0 | $0 | 0.00% | −93−100.0% | Sold out |
| Credit Agricole S A | – | – | – | – | Not filed |
| Lindbrook Capital, LLC | – | – | – | – | Not filed |